Scienture (NASDAQ:SCNX) Posts Earnings Results

Scienture (NASDAQ:SCNXGet Free Report) released its earnings results on Thursday. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.02, FiscalAI reports. The business had revenue of $0.34 million for the quarter, compared to analysts’ expectations of $1.96 million.

Scienture Trading Up 0.2%

NASDAQ:SCNX traded up $0.00 on Friday, reaching $0.47. 29,546,620 shares of the stock traded hands, compared to its average volume of 1,967,245. The company has a market capitalization of $18.93 million, a price-to-earnings ratio of -0.22 and a beta of 3.26. Scienture has a 12 month low of $0.24 and a 12 month high of $2.60. The company’s fifty day simple moving average is $0.38 and its 200 day simple moving average is $0.40.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Scienture in a research note on Wednesday, June 24th. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $1.50.

Read Our Latest Stock Report on Scienture

Institutional Investors Weigh In On Scienture

An institutional investor recently bought a new stake in Scienture stock. Virtu Financial LLC purchased a new stake in shares of Scienture Holdings, Inc. (NASDAQ:SCNXFree Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 89,930 shares of the company’s stock, valued at approximately $46,000. Virtu Financial LLC owned approximately 0.22% of Scienture as of its most recent SEC filing. 5.68% of the stock is currently owned by institutional investors and hedge funds.

Scienture Company Profile

(Get Free Report)

Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.

Read More

Earnings History for Scienture (NASDAQ:SCNX)

Receive News & Ratings for Scienture Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scienture and related companies with MarketBeat.com's FREE daily email newsletter.